Literature DB >> 19309729

Structure of dystrophia myotonica protein kinase.

Jonathan M Elkins1, Ann Amos, Frank H Niesen, Ashley C W Pike, Oleg Fedorov, Stefan Knapp.   

Abstract

Dystrophia myotonica protein kinase (DMPK) is a serine/threonine kinase composed of a kinase domain and a coiled-coil domain involved in the multimerization. The crystal structure of the kinase domain of DMPK bound to the inhibitor bisindolylmaleimide VIII (BIM-8) revealed a dimeric enzyme associated by a conserved dimerization domain. The affinity of dimerisation suggested that the kinase domain alone is insufficient for dimerisation in vivo and that the coiled-coil domains are required for stable dimer formation. The kinase domain is in an active conformation, with a fully-ordered and correctly positioned alphaC helix, and catalytic residues in a conformation competent for catalysis. The conserved hydrophobic motif at the C-terminal extension of the kinase domain is bound to the N-terminal lobe of the kinase domain, despite being unphosphorylated. Differences in the arrangement of the C-terminal extension compared to the closely related Rho-associated kinases include an altered PXXP motif, a different conformation and binding arrangement for the turn motif, and a different location for the conserved NFD motif. The BIM-8 inhibitor occupies the ATP site and has similar binding mode as observed in PDK1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309729      PMCID: PMC2762590          DOI: 10.1002/pro.82

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  42 in total

1.  Structural insights into the interaction of ROCKI with the switch regions of RhoA.

Authors:  Radovan Dvorsky; Lars Blumenstein; Ingrid R Vetter; Mohammad Reza Ahmadian
Journal:  J Biol Chem       Date:  2003-12-02       Impact factor: 5.157

2.  The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module.

Authors:  Natarajan Kannan; Nina Haste; Susan S Taylor; Andrew F Neuwald
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

3.  Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil.

Authors:  Hiroto Yamaguchi; Miyuki Kasa; Mutsuki Amano; Kozo Kaibuchi; Toshio Hakoshima
Journal:  Structure       Date:  2006-03       Impact factor: 5.006

4.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

5.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

Review 6.  RNA pathogenesis of the myotonic dystrophies.

Authors:  John W Day; Laura P W Ranum
Journal:  Neuromuscul Disord       Date:  2004-11-26       Impact factor: 4.296

7.  Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif.

Authors:  Albrecht Messerschmidt; Sofia Macieira; Milko Velarde; Mathias Bädeker; Christian Benda; Anja Jestel; Hans Brandstetter; Torsten Neuefeind; Michael Blaesse
Journal:  J Mol Biol       Date:  2005-09-30       Impact factor: 5.469

8.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

Authors:  Majid Fardaei; Mark T Rogers; Helena M Thorpe; Kenneth Larkin; Marion G Hamshere; Peter S Harper; J David Brook
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

Review 9.  Myotonic dystrophy: RNA pathogenesis comes into focus.

Authors:  Laura P W Ranum; John W Day
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

10.  Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure.

Authors:  David Komander; Ritu Garg; Paul T C Wan; Anne J Ridley; David Barford
Journal:  EMBO J       Date:  2008-10-23       Impact factor: 11.598

View more
  8 in total

Review 1.  Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1.

Authors:  Zhuoshen Zhao; Ed Manser
Journal:  Small GTPases       Date:  2015-06-19

Review 2.  Biophysical characterization of recombinant proteins: a key to higher structural genomics success.

Authors:  Masoud Vedadi; Cheryl H Arrowsmith; Abdellah Allali-Hassani; Guillermo Senisterra; Gregory A Wasney
Journal:  J Struct Biol       Date:  2010-05-11       Impact factor: 2.867

Review 3.  Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions.

Authors:  Linda Julian; Michael F Olson
Journal:  Small GTPases       Date:  2014-07-10

4.  Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.

Authors:  Timo Heikkila; Edward Wheatley; Diane Crighton; Ewald Schroder; Alexandra Boakes; Sarah J Kaye; Mokdad Mezna; Leon Pang; Mathew Rushbrooke; Andrew Turnbull; Michael F Olson
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

5.  Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1.

Authors:  Barbara Franke; Alexander Gasch; Dayté Rodriguez; Mohamed Chami; Muzamil M Khan; Rüdiger Rudolf; Jaclyn Bibby; Akira Hanashima; Julijus Bogomolovas; Eleonore von Castelmur; Daniel J Rigden; Isabel Uson; Siegfried Labeit; Olga Mayans
Journal:  Open Biol       Date:  2014-03-26       Impact factor: 6.411

6.  Revealing phosphorylation regulatory networks during embryogenesis of honey bee worker and drone (Apis mellifera).

Authors:  Beibei Ma; Chuan Ma; Jianke Li; Yu Fang
Journal:  Front Cell Dev Biol       Date:  2022-09-26

Review 7.  The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer.

Authors:  Mathieu Unbekandt; Michael F Olson
Journal:  J Mol Med (Berl)       Date:  2014-02-20       Impact factor: 4.599

Review 8.  Made to measure - keeping Rho kinase at a distance.

Authors:  Linda Truebestein; Daniel J Elsner; Thomas A Leonard
Journal:  Small GTPases       Date:  2016-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.